Results 241 to 250 of about 18,995 (290)

Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison. [PDF]

Cancer Rep (Hoboken)
Chen W, Yoshida S, Fujii Y.
europepmc   +1 more source

Pharmacokinetics of a Single Subcutaneous Extended‐Release Buprenorphine (Ethiqa XR) in Healthy Beagles

Journal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT This study evaluated the pharmacokinetics of an extended‐release buprenorphine formulation (Ethiqa XR) in dogs and explored potential sex differences. Twelve healthy intact beagles (6 males and 6 females) received a single subcutaneous injection of Ethiqa XR (0.2 mg/kg).
Kornelia Tiffinger, Hiroko Enomoto, Ronald E. Baynes, Laura M. Neumann, B. Duncan X. Lascelles, Masataka Enomoto   +5 more
wiley   +1 more source

Association Between Long-term Use of H₂ Receptor Antagonists and Prostate Cancer Risk: A Case-Control Study in Taiwan. [PDF]

J Cancer
Wang SF, Liu YC, Nguyen PA, Lin GL, Huang CW, Rahmanti AR, Yang HC.   +6 more
europepmc   +1 more source

Tumor proliferation associates with greater sensitivity to androgen receptor pathway inhibition in metastatic prostate cancer. [PDF]

J Clin Invest
Mendes L, Dutey-Magni PF, Grist E, Sachdeva A, Santos Vidal S, Lall S, Parry MA, Amos CL, Atako N, Wingate A, Wetterskog D, Sydes MR, Parker CC, Clarke N, Sweeney CJ, Parmar MK, Brown LC, James ND, Berney DM, Attard G.   +19 more
europepmc   +1 more source

Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01. [PDF]

Future Oncol
Azad AA, Agarwal N, Armstrong AJ, Hellmis E, Sugimoto M, Ürün Y, Xing N, Aregay M, Lima J, Meulendijks D, Chi KN.   +10 more
europepmc   +1 more source

Androgenetic alopecia in polycystic ovary syndrome: a cutaneous marker of systemic metabo-inflammatory and endocrine dysfunction. [PDF]

Endocr Connect
Motafeghi F, Saei Ghare Naz M, Ramezani Tehrani F, Behboudi-Gandevani S.   +3 more
europepmc   +1 more source

Behavioral Alterations in Male Zebrafish After Administration of Androgen Receptor Blockers and an Activator. [PDF]

Biology (Basel)
Huang CY, Audira G, Vasquez RD, Alos HC, Lin HY, Hsiao CD, Hung CH.   +6 more
europepmc   +1 more source

Androgen metabolism in prostate cancer: recent advances.

Endocrinology
Sharifi N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recent Developments in Androgen Receptor Antagonists

Archiv Der Pharmazie, 2015
The androgen receptor (AR), a ligand‐dependent transcription factor that regulates the expression of a series of downstream target genes after the binding of androgens, has been a target for the discovery of drugs used to treat prostate cancer. Prostate cancer always progresses to castration‐resistant prostate cancer after a period of androgen ...
Daoguang Zhang, Guisen Zhao
exaly   +3 more sources